Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review

References

• Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200:327–331.
   PubMed Web of Science ®Google Scholar
• Midthun DE, Swensen SJ, Jett JR. Approach to the solitary pulmonary nodule. Mayo Clin Proc. 1993;68:378–385.
   PubMed Web of Science ®Google Scholar
• Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004;126:114–121.
   PubMed Web of Science ®Google Scholar
• Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003;226:756–761.
   PubMed Web of Science ®Google Scholar
• Divisi D, Imbriglio G, De Vico A, et al. Lung nodule management: a new classification proposal. Minerva Chir. 2011;66:223–234.
   PubMed Web of Science ®Google Scholar
• Detterbeck FC, Mazzone PJ, Naidich DP, et al. Screening for lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2013;143(Suppl. 5):e78S–e92S.
   Web of Science ®Google Scholar
• National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
   PubMed Web of Science ®Google Scholar
• Steele JD. The solitary pulmonary nodule. Report of a cooperative study of resected asymptomatic solitary pulmonary nodules in male. J Thorac Cardiovasc Surg. 1963;46:21–39.
   PubMed Web of Science ®Google Scholar
• Van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assesment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and III A. Chest. 2000;117:374–379.
   PubMed Web of Science ®Google Scholar
• Asamura H, Goya T, KoshiishiY, et al. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg. 2006; 32:116–119.
   Google Scholar
• Kameyama K, Takahashi M, Ohata K, et al. Evaluation of the new TNM staging system proposed by the International Association for the study of lung cancer at a single institution. J Thorac Cardiovasc Surg. 2009;137:1180–1184.
   PubMed Web of Science ®Google Scholar
• MacMahon H, Austin JHM, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner society. Radiology. 2005;237:395–400.
   PubMed Web of Science ®Google Scholar
• Henschke CI. Computed tomography screening for lung cancer: principles and results. Clin Cancer Res. 2005;11:4984s–4987s.
   PubMed Web of Science ®Google Scholar
• Tan BB, Flaherty KR, Kazerooni EA, et al. The solitary pulmonary nodule. Chest. 2003;123:89S–96S.
   PubMed Web of Science ®Google Scholar
• Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235:259–265.
   PubMed Web of Science ®Google Scholar
• Swensen SJ. CT screening for lung cancer. AJR Am J Roentgenol. 2002;179:833–836.
   PubMed Web of Science ®Google Scholar
• Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304–317.
   PubMed Web of Science ®Google Scholar
• Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(Suppl. 5): e93S–120S.
   Web of Science ®Google Scholar
• Acker MR, Burrell SC. Utility of 18F-FDG PET in evaluating cancers of lung. J Nucl Med Technol. 2005;33:69–74.
   PubMedGoogle Scholar
• Gilman MD, Aquino SL. State-of-the-Art FDG-PET imaging of lung cancer. Semin Roentgenol. 2005;40:143–153.
   PubMed Web of Science ®Google Scholar
• Higashi K, Matsunari I, Ueda Y, et al. Value of whole-body FDG PET in management of lung cancer. Ann Nucl Med. 2003;17:1–14.
   PubMed Web of Science ®Google Scholar
• Ylmaz F, Tastekin G. Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules. Int J Clin Exp Med. 2015;8:45–51.
   PubMed Web of Science ®Google Scholar
• Herder GJ, Golding RP, Hoekstra OS, et al. The performance of (18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2004;31:1231–1236.
   PubMed Web of Science ®Google Scholar
• Khalaf M, Abdel-Nabi H, Baker J, et al. Relation between nodule size and 18F-FDG PET SUV for malignant and benign pulmonary nodules. J Hematol Oncol. 2008;22:1–13.
   Google Scholar
• Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point (18) F-FDG PET imaging for the differentiation between malignant and benign lesion. Clin Radiol. 2008;63:756–764.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Lei J, et al. Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis. Acta Radiol. 2013;54:770–777.
   PubMed Web of Science ®Google Scholar
• Deppen S, Blume JD, Kensinger CD, et al. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. JAMA 2014;312:1227–1236.
   PubMed Web of Science ®Google Scholar
• Deppen S, Putnam JB Jr, Andrade G, et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg. 2011;92:428–432.
   PubMed Web of Science ®Google Scholar
• Van Gomez Lopez O, Garcia Vicente AM, Honguero Martinez AF, et al. (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy. J Hematol Oncol. 2015;4:228–235.
   Google Scholar
• Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48:214–220.
   PubMed Web of Science ®Google Scholar
• Opoka L, Kunikowska J, Podgajny Z, et al. Accuracy of FDG PET/CT in the evaluation of solitary pulmonary lesions - own experience. Pneumonol Alergol Pol. 2014;82:198–205.
   PubMedGoogle Scholar
• Sim YT, Goh YG, Dempsey MF, et al. PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology. Lung. 2013;191:625–632.
   PubMed Web of Science ®Google Scholar
• Li Y, Su M, Li F, et al. The value of 18F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis. Ann Nucl Med. 2011;25:804–811.
   PubMed Web of Science ®Google Scholar
• Demir Y, Polack BD, Karaman C, et al. The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules. Nucl Med Commun. 2014;35:260–267.
   PubMed Web of Science ®Google Scholar
• Li S, Zhao B, Wang X, et al. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: analysis of 298 patients. Clin Radiol. 2014;69:e352–e357.
   PubMed Web of Science ®Google Scholar
• Divisi D, Di Tommaso S, Di Leonardo G, et al. 18-fluorine fluorodeoxyglucose positron emission tomography alone for the management of solitary lung nodule with diameters inferior to 1.5 cm. Thorac cardiovasc Surg. 2010;58:422–426.
   PubMed Web of Science ®Google Scholar
• Callister ME, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015;70:ii1–ii54.
   PubMed Web of Science ®Google Scholar
• Yi CA, Lee KS, Kim BT, et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med. 2006;47:443–450.
   PubMed Web of Science ®Google Scholar
• Kagna O, Solomonov A, Keidar Z, et al. The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer. Eur J Nucl Med Mol Imaging. 2009;36:997–1004.
   PubMed Web of Science ®Google Scholar
• Harders SW, Madsen HH, Hjorthaug K, et al. Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [18F]fluorodeoxyglucose-positron emission tomography/computed tomography. Cancer Imaging. 2012;12:437–446.
   PubMed Web of Science ®Google Scholar
• Dabrowska M, Krenke R, Korczynski P, et al. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules. Medicine. 2015;94:e666.
   PubMed Web of Science ®Google Scholar
• Godoy MCB, Naidich DP. Overview and strategic management of subsolid pulmonary nodules. J Thorac Imaging. 2012;27:240–248.
   PubMed Web of Science ®Google Scholar
• Ferretti G, Félix L, Serra-Tosio G, et al. Non-solid and part-solid pulmonary nodules on CT scanning. Rev Mal Respir. 2007;24:1265–1276.
   PubMed Web of Science ®Google Scholar
• Henschke CI, Yankelevitz DF, Mirtcheva R, et al.; ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002;178:1053–1057.
   PubMed Web of Science ®Google Scholar
• de Hoop B, van Ginneken B, Gietema H, et al. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology. 2012;265:611–616.
   PubMed Web of Science ®Google Scholar
• Lu CH, Hsiao CH, Chang YC, et al. Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation. J Thorac Oncol. 2012;7:143–150.
   PubMed Web of Science ®Google Scholar
• Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007;245:267–275.
   PubMed Web of Science ®Google Scholar
• Seidelman JL, Myers JL, Quint LE. Incidental, subsolid pulmonary nodules at CT: etiology and management. Cancer Imaging. 2013;13:365–373.
   PubMed Web of Science ®Google Scholar
• Collins J, Stern EJ. Ground-glass opacity at CT: the ABCs. AJR Am J Roentgenol. 1997;169:355–367.
   PubMed Web of Science ®Google Scholar
• Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (<or =1cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol. 2003;180:955–964.
   PubMed Web of Science ®Google Scholar
• Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr. 2002;26:323–329.
   PubMed Web of Science ®Google Scholar
• Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. JCO. 2005;23:3279–3287.
   PubMed Web of Science ®Google Scholar
• Kawakami S, Sone S, Takashima S, et al. Atypical adenomatous hyperplasia of the lung: correlation between high-resolution CT findings and histopathologic features. Eur Radiol. 2001;11:811–814.
   PubMed Web of Science ®Google Scholar
• Park CM, Goo JM, Lee HJ, et al. CT findings of atypical adenomatous hyperplasia in the lung. Korean J Radiol. 2006;7:80–86.
   PubMed Web of Science ®Google Scholar
• Christiani DC, Pao W, DeMartini JC, et al. BAC consensus conference, November 4-6, 2004: epidemiology, pathogenesis, and preclinical models. J Thorac Oncol. 2006;1:S2–S7.
   PubMed Web of Science ®Google Scholar
• Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844–2852.
   PubMed Web of Science ®Google Scholar
• Travis WD, Colby TV, Corrin B, et al. World Health Organisation. International Histological Classification of Tumours. Histological typing of lung and pleural tumours. 3rd ed. Berlin, Germany: Springer-Verlag; 1999.
   Google Scholar
• Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World Health Organisation Classification of Tumours. Pathology & Genetics. Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.
   Google Scholar
• Kim TJ, Park CM, Goo JM, et al. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? AJR Am J Roentgenol. 2012;198:83–88.
   PubMed Web of Science ®Google Scholar
• Erasmus JJ, Rohren E, Swisher SG. Prognosis and reevaluation of lung cancer by positron emission tomography imaging. Proc Am Thorac Soc. 2009;6:171–179.
   PubMedGoogle Scholar
• Um SW, Kim H, Koh WJ, et al. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. J Thorac Oncol. 2009;4:1331–1336.
   PubMed Web of Science ®Google Scholar
• Weber WA, Petersen V, Schmidt B, et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. JCO. 2003;21:2651–2657.
   PubMed Web of Science ®Google Scholar
• Lee SM, Park CM, Paeng JC, et al. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Eur Radiol. 2012;22:1556–1563.
   PubMed Web of Science ®Google Scholar
• Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124:278–284.
   PubMed Web of Science ®Google Scholar
• Nomori H, Watanabe K, Ohtsuka T, et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004;45:19–27.
   PubMed Web of Science ®Google Scholar
• Goudarzi B, Jacene HA, Wahl RL. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT. J Nucl Med. 2008;49:1585–1592.
   PubMed Web of Science ®Google Scholar
• Port JL, Andrade RS, Levin MA, et al. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg. 2005;130:1611–1615.
   PubMed Web of Science ®Google Scholar
• Tsutani Y, Miyata Y, Nakayama H, et al. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. J Thorac Cardiovasc Surg. 2012;144:1365–1371.
   PubMed Web of Science ®Google Scholar
• Okada M, Nakayama H, Okumura S, et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141:1384–1391.
   PubMed Web of Science ®Google Scholar
• Yap CS, Schiepers C, Fishbein MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging. 2002;29:1166–1173.
   PubMed Web of Science ®Google Scholar
• Heyneman LE, Patz EF. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer. 2002;38:261–266.
   PubMed Web of Science ®Google Scholar